Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$739
-$71 QoQ
Shares Held
150
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#205
of 220 holders
Holding Since
Sep 2024
8 quarters on record
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Park Place Capital Corp holds $531,260 across 7 Drug Manufacturers - Specialty & Generic names. BHC ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,611 | $403,206 | |
| 2 | HLN |
Haleon plc
|
10,562 | $98,543 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
543 | $18,396 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
14 | $7,585 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
16 | $2,696 | |
| 6 | BHC |
Bausch Health Companies Inc.
This page
|
150 | $739 | |
| 7 | VTRS |
Viatris Inc
|
6 | $95 |
All Filings in BHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $739 | 150 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $810 | 150 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,042 | 150 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $967 | 150 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $999 | 150 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $970 | 150 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,209 | 150 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,224 | 150 | Shares | Sole | 2024-10-08 | |
| No filing history on record for this holder in this stock. | ||||||